Skip to main content

Table 4 Number of patients in each group who reported adverse events.

From: Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial

  Placebo Paroxetine
nausea 0 4
loss of appetite 1 4
headache 0 1
confusion 0 1
sedation 0 1
flatulence 1 0
hypoglycaemia 0 1
hyperglycaemia 1 0
erectile dysfunction 2 0
sweating 1 1